Challenge areas to be addressed

Human development (Details: Healthcare)

Overview

Bioscafil is a biotech startup developing implantable scaffold-based therapies for targeted drug delivery in cancer and autoimmune diseases. We aim to improve treatment efficacy while minimizing systemic side effects through localized, biodegradable solutions.

Target region / country

Japan, South Asia, North America – India/Japan/Korea/USA

Details

Bioscafil is developing patentable scaffold-based drug delivery systems using proprietary polymer formulations tailored for disease-specific applications. While currently in stealth mode, we are preparing for scientific publications and targeted media outreach post-prototype validation.

Category

Know-how, Research institution, Technology, Intellectual property rights (patents/trademarks etc.), Customer base

Details

Human Resources: We seek access to skilled professionals in biomedical R&D, clinical planning, and healthcare marketing to accelerate Bioscafil’s product development and adoption. Fundraising Support: We request guidance and connections for equity-based pre-seed and seed-stage fundraising to scale our scaffold therapy platform.

Category

Human resources, Network/Connection, Funding (investment/subsidies/donations etc.), Media

Reference (JICA-owned assets)

• The Challenges and Business Needs of Developing Countries
• JICA Global Agenda

Nagoya